GMAB

GENMAB A/S

GMAB·372303206·US·ADR·Healthcare - Biotechnology

GMAB (GENMAB A/S) is held by 120 institutional investors as of Q2 2026. Largest holders: Orbis Allan Gray Ltd ($312.3M), ALLIANCEBERNSTEIN L.P. ($231.9M), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ($136.7M). Net institutional sentiment: Mixed.

120
Holders
(10 Elite)
$1.9B
Total Value
55% (122)
Consensus
67 buying - 55 selling
13F: Insider & Congress: Updated regularly
GMAB

Smart Money Verdict

View all
Loading verdict
Held by 120 funds
10 elite

Who's Trading

Source dates: Price Sep 18, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for GMAB.

Top Holders

Checking access…
Action
Decreased
11.4M(-12.1%)$312.3M1.1%+34.84%
0
Decreased
8.6M(-9.6%)$231.9M0.1%+3.16%
0
Unchanged
5M$136.7M0.1%+44.42%
0
Increased
4.7M(+3.0%)$128.3M0.0%+41.88%
31
Decreased
3.5M(-20.3%)$96.6M0.1%+19.35%
0
Increased
3.5M(+49.9%)$96.3M0.1%+29.26%
41
Decreased
3.1M(-4.5%)$86.9M0.8%+11.19%
0
Increased
2.8M(+12.0%)$75.7M0.0%+20.89%
33
New
2.5M$68M0.0%+24.32%
41
Increased
1.7M(+149.4%)$46.4M0.0%+23.57%
47
Decreased
1.6M(-25.4%)$44.8M0.0%+39.67%
0
Increased
1.4M(+15.8%)$39.8M0.1%+18.58%
34
Increased
1.3M(+37.4%)$35.1M0.0%+37.18%
38
Increased
1.2M(+0.8%)$33M0.0%+22.44%
29
Decreased
1.1M(-1.1%)$29.3M0.0%+8.45%
0
Increased
961,053(+222.4%)$26.4M0.0%+24.65%
46
Decreased
916,600(-3.6%)$25.2M0.0%+24.06%
0
Increased
910,604(+14.9%)$25M0.0%+24.05%
33
Increased
883,430(+10.8%)$24.3M0.0%+57.05%
32
Decreased
829,687(-3.8%)$22.8M0.0%+2.78%
0

Showing 1-20 of 126

1 / 7
GMABGMABGENMAB A/S

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used